LARP1BP3

Across TCGA pan-cancer cohorts, LARP1BP3 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LARP1BP3 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LARP1BP3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LARP1BP3 expression acts as an unfavorable survival marker.

BLCA, OV, and UCS are the cancer types where LARP1BP3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.196	0.514	.004	54	view →
OV	DFS	Tertile	All	0.282	0.542	.020	54	view →
UCS	DFS	Tertile	All	0.182	0.528	.036	54	view →
SKCM	DFS	Tertile	All	0.226	0.736	<.001	45	view →
ESCA	OS	Tertile	IV	0.135	0.568	.031	36	view →
KIRC	DFS	Tertile	IV	0.157	0.638	.012	18	view →
LIHC	DFS	Tertile	All	0.153	0.555	.024	18	view →
LGG	DFS	Tertile	All	0.189	0.461	.044	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
THCA	DFS	Tertile	All	0.427	0.815	.013	9	view →
BRCA	OS	Tertile	III,IV	0.777	0.905	.048	6	view →
PRAD	OS	Tertile	All	0.932	0.990	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LARP1BP3–BLCA (DFS)

Open the BLCA breakdown →